Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens
Ken Saijo(Tohoku University), Chikashi Ishioka(Tohoku University), Masanobu Takahashi(Shibaura Institute of Technology), Yoshifumi Kawamura(Tohoku University), Yuya Yoshida(Tohoku University), Keiju Sasaki(Tohoku University), Sakura Taniguchi(Tohoku University), Hidekazu Shirota(Tohoku University), Kota Ouchi(Tohoku University), Yuki Kasahara(Tohoku University), Hiroo Imai(Tohoku University), Keigo Komine(Tohoku University)
Cited by 10
Related Papers
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
|Nature|2011|388
MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
|The EMBO Journal|2014|302
Human protein factory for converting the transcriptome into an in vitro–expressed proteome
|Nature Methods|2008|269
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
|Molecular Cancer Therapeutics|2006|243
Differential Contributions of<i>BRCA1</i>and<i>BRCA2</i>to Early-Onset Breast Cancer
|New England Journal of Medicine|1997|211